In addition, Sagredo et al. recently showed that TRPM4 knockdown significantly reduce the proliferation of PC3 cells [107]. Thus, TRPM4 represents an interesting putative target in prostate cancer therapy. Here, TRPM4 is linked to prostate cancer.